CD8A and neoplasm: It has recently been reported that spontaneous and immunotherapy-induced antitumor responses require the activity of tumor antigen-specific CD8+ and CD4+ T cells, even in tumors that do not express MHC-II molecules, indicating that CD4+ T cells, which recognize antigens displayed by MHC-II, are necessary to eliminate tumors (Alspach et al., 2019).